Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapyToby A. Eyre, Graham P. Collins, Matt Cross et al.|Haematologica|2018Cited by 137
UK clinical practice guidelines for the management of patients with constitutional <i>POT1</i> pathogenic variantsOlga Tsoulaki, Helen Hanson, D Gareth Evans et al.|Journal of Medical Genetics|2025Cited by 8